Yet GSK is clearly healing from its multiple comorbidities — the worst of which was the (now largely resolved) legal overhang related to heartburn medicine Zantac. Chief executive Emma Walmsley also ...
The world’s biggest drugmaker Eli Lilly has forecast that profits for the year will beat expectations, after two choppy quarters when disappointing sales of its blockbuster weight-loss drugs led to ...
"The uncertainty caused by potential tariffs on Canadian goods and newly-imposed tariffs on China has made it very difficult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback